Original language | English |
---|---|
Pages (from-to) | 436S |
Number of pages | 1 |
Journal | Journal of Clinical Oncology |
Volume | 24 |
Issue number | 18 |
Publication status | Published - 20 Jun 2006 |
Event | 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - Atlanta, United States Duration: 2 Jun 2006 → 6 Jun 2006 |
Defining Burkitt's lymphoma (BL) with cytogenetics: LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL).
J. Walewski, G. Mead, A. Jack, S. Barrans, J. Radford, S. Clawson, S. Stenning, W. Qian, Natl Canc Res Inst Lymphoma Gr
Research output: Contribution to journal › Meeting Abstract › peer-review